h14A043-ATAC

N/A

Report date: 2024/02/05 14:05:07

Base Information

Drug Nameh14A043-ATAC

Drug Alias Nameh14A043-ATAC

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Amanitin payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionCUB domain-containing protein 1 modulators

TargetsCUB domain-containing protein 1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChiome Bioscience Inc

China Registration ClassN/A

Develop Information

Active CompaniesChiome Bioscience Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A